309 related articles for article (PubMed ID: 17202144)
1. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
[TBL] [Abstract][Full Text] [Related]
2. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
Yanase T; Fan W
Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
[TBL] [Abstract][Full Text] [Related]
3. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
Liu P; Li S; Gan L; Kao TP; Huang H
Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
[TBL] [Abstract][Full Text] [Related]
4. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
[TBL] [Abstract][Full Text] [Related]
5. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
[TBL] [Abstract][Full Text] [Related]
6. The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.
Mediwala SN; Sun H; Szafran AT; Hartig SM; Sonpavde G; Hayes TG; Thiagarajan P; Mancini MA; Marcelli M
Prostate; 2013 Feb; 73(3):267-77. PubMed ID: 22821817
[TBL] [Abstract][Full Text] [Related]
7. Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts.
Yang S; Xu H; Yu S; Cao H; Fan J; Ge C; Fransceschi RT; Dong HH; Xiao G
J Biol Chem; 2011 May; 286(21):19149-58. PubMed ID: 21471200
[TBL] [Abstract][Full Text] [Related]
8. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
Yan Y; Huang H
Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
Gan L; Chen S; Wang Y; Watahiki A; Bohrer L; Sun Z; Wang Y; Huang H
Cancer Res; 2009 Nov; 69(21):8386-94. PubMed ID: 19826044
[TBL] [Abstract][Full Text] [Related]
10. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
[TBL] [Abstract][Full Text] [Related]
11. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
12. The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.
Song CH; Lee HJ; Park E; Lee K
PLoS One; 2012; 7(11):e49026. PubMed ID: 23145053
[TBL] [Abstract][Full Text] [Related]
13. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
[TBL] [Abstract][Full Text] [Related]
14. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.
Ma Q; Fu W; Li P; Nicosia SV; Jenster G; Zhang X; Bai W
Mol Endocrinol; 2009 Feb; 23(2):213-25. PubMed ID: 19074551
[TBL] [Abstract][Full Text] [Related]
15. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
18. FOXO1 is regulated by insulin and IGF1 in pituitary gonadotropes.
Skarra DV; Thackray VG
Mol Cell Endocrinol; 2015 Apr; 405():14-24. PubMed ID: 25676570
[TBL] [Abstract][Full Text] [Related]
19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
20. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
